Abstract:Background: Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5), which is identified as a novel intestinal stem cell marker, is overexpressed in various tumours. In this study, we explore Lgr5 expression in gastric carcinoma and analyse its role in invasion, metastasis, and prognosis in carcinoma. Methods: A combination of immunohistochemistry, western blotting, and quantitative reverse transcription–polymerase chain reaction were used to detect mRNA and protein expression levels of Lgr5 and matrix metalloproteinase 2 (MMP2). Small interfering RNA against Lgr5 was designed, synthesised, and transfected into AGS cells. The effects of Lgr5 siRNA on cell invasion were detected by transwell invasion chamber assay and wound healing assay. Results: Leucine-rich repeat-containing G-protein-coupled receptor 5 expression was significantly higher in gastric carcinomas than in normal mucosa. Leucine-rich repeat-containing G-protein-coupled receptor 5 expression positively correlated with the depth of invasion, lymph node metastasis, distance of metastasis, and MMP2 expression levels. Multivariate analysis showed that Lgr5 had an independent effect on survival, and that it positively correlated with MMP2. Leucine-rich repeat-containing G-protein-coupled receptor 5 siRNAs inhibited Lgr5 mRNA and protein expression. Transwell assays indicated that these siRNAs resulted in significantly fewer cells migrating through the polycarbonate membrane, and wound healing assay also indicated that siRNAs decreased the migration of cells. Inhibition of Lgr5 resulted in a significant decrease in MMP2 and β -catenin levels compared with those in controls. Conclusions: Leucine-rich repeat-containing G-protein-coupled receptor 5 was correlated with invasion and metastasis. Leucine-rich repeat-containing G-protein-coupled receptor 5 inhibition could serve as a novel therapeutic approach.

LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition.

The Prognostic Role of Eg5 Expression in Laryngeal Squamous Cell Carcinoma.

Lgr5 Promotes Epithelial Ovarian Cancer Proliferation, Metastasis, And Epithelial-Mesenchymal Transition Through The Notch1 Signaling Pathway

Expression of LGR5 in hepatoma cells, HCC tissue and its significance

LGR5 Promotes the Proliferation of Colorectal Cancer Cells Via the Wnt/β-catenin Signaling Pathway.

LGR5 is a Promising Biomarker for Patients with Stage I and II Gastric Cancer.

Eg5 As a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma

Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma.

Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer

Exploring LGR5 as a prognostic marker of extrahepatic cholangiocarcinoma: insights from expression analysis and clinical correlations

Over-Expression of Regulator of G Protein Signaling 5 Promotes Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells

LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer

Long Non-Coding RNA CASC15 is Upregulated in Hepatocellular Carcinoma and Facilitates Hepatocarcinogenesis.

Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.

LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis.

Lgr5 is A Potential Prognostic Marker in Patients with Cervical Carcinoma

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

LGR5, a prognostic stem cell target, promotes endometrial cancer proliferation through autophagy activation

Leucine‐rich repeat‐containing G protein‐coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications

Prognostic Value Of Lgr5 In Colorectal Cancer: A Meta-Analysis

LGR5 Promotes the Proliferation and Tumor Formation of Cervical Cancer Cells Through the Wnt/β-catenin Signaling Pathway